CytomX Therapeutics (CTMX) Other Gross PP&E Adjustments: 2014-2025
Historic Other Gross PP&E Adjustments for CytomX Therapeutics (CTMX) over the last 10 years, with Sep 2025 value amounting to -$5.5 million.
- CytomX Therapeutics' Other Gross PP&E Adjustments rose 48.94% to -$5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.0 million, marking a year-over-year increase of 74.80%. This contributed to the annual value of $9.9 million for FY2024, which is 222.48% up from last year.
- According to the latest figures from Q3 2025, CytomX Therapeutics' Other Gross PP&E Adjustments is -$5.5 million, which was up 24.35% from -$7.3 million recorded in Q2 2025.
- Over the past 5 years, CytomX Therapeutics' Other Gross PP&E Adjustments peaked at $9.9 million during Q4 2024, and registered a low of -$23.0 million during Q2 2021.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$10.9 million (2024), whereas its average is -$9.1 million.
- Data for CytomX Therapeutics' Other Gross PP&E Adjustments shows a peak YoY surged of 222.48% (in 2024) over the last 5 years.
- Quarterly analysis of 5 years shows CytomX Therapeutics' Other Gross PP&E Adjustments stood at -$15.0 million in 2021, then rose by 25.08% to -$11.2 million in 2022, then climbed by 28.10% to -$8.1 million in 2023, then surged by 222.48% to $9.9 million in 2024, then surged by 48.94% to -$5.5 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$5.5 million for Q3 2025, versus -$7.3 million for Q2 2025 and -$8.0 million for Q1 2025.